NEW YORK (GenomeWeb News) – Persistent Systems today announced that it has partnered with Life Technologies to develop a new software platform for the analysis of sequencing data generated by capillary electrophoresis instruments.
Persistent and the Fragment and Sequence Genomics division of Life Tech will build the sequencing and fragment analysis software for CE sequencing platforms that will be submitted for approval by the US Food and Drug Administration, Persistent said. The software solutions company, which has offices in India and San Jose, Calif., also will provide services to integrate assays from third-party vendors.
The new platform "represents an advanced genomic technology for clinics taking a step towards making personalized medicine a reality to combat critical human diseases like cancer," Persistent said in a statement.
Financial and other terms of the deal were not disclosed.
"Our partnership with Persistent Systems allow us to take the next step in developing molecular diagnostic solutions that leverage our gold standard sequencing and fragment analysis technology," said Todd Laird, VP and general manager of Life Tech's Fragment and Sequence Genomics division.
Life Tech officials confirmed the alliance but declined to provide additional details.